Chenet A, Perrouin-Verbe B, Le Normand L, Labat J-J, Brunel P, Lefort M, Mathé J-F
Service de médecine physique et réadaptation neurologique, hôpital Saint-Jacques, CHU de Nantes, 85, rue Saint-Jacques, 44093 Nantes cedex, France.
Ann Readapt Med Phys. 2007 Nov;50(8):651-60. doi: 10.1016/j.annrmp.2007.03.019. Epub 2007 Apr 20.
Toxin injections are an effective treatment for neurogenic detrusor overactivity. The efficacy of repeat injections is not well documented. The objective of this study was to evaluate the efficacy of repeat injections of toxin A to the detrusor in patients with neurogenic overactive bladders.
Patients who had received 300-UI injections of Botox(R) were retrospectively studied. The clinical data included continence, duration of the absence of incontinence, changes in anticholinergic dosage or pad use and patient satisfaction. Urodynamic data analyzed were maximal cystometric capacity, bladder contraction and detrusor pressure during contraction. Data were analyzed by Wilcoxon and Kruskal-Wallis tests. RESULTS-DISCUSSION: Data for 42 patients (30 men, 12 women) were analysed. Pathologic features were trauma to the spinal cord, multiple sclerosis or varied causes of myelopathy. Patients received 1 to 6 injections of Botox(R). The mean duration of efficacy was 6 months. Efficacy did not differ among successive injections. Anticholinergic drugs were discontinued in 43% of patients and pad use in 48%. A total of 80% of the patients were satisfied with the treatment. Bladder contraction disappeared in 70% of patients. The mean maximal cystometric capacity increase was 144 ml.
Clinical and urodynamic data show that repeat injection of toxins to the detrusor remains an effective therapy for neurogenic bladder overactivity. Efficacy for continence is maintained during successive injections.
毒素注射是治疗神经源性逼尿肌过度活动症的有效方法。重复注射的疗效尚无充分记录。本研究的目的是评估对神经源性膀胱过度活动症患者重复向逼尿肌注射毒素A的疗效。
对接受过300单位保妥适注射的患者进行回顾性研究。临床数据包括控尿情况、无尿失禁持续时间、抗胆碱能药物剂量或护垫使用情况的变化以及患者满意度。分析的尿动力学数据包括最大膀胱测压容量、膀胱收缩及收缩期逼尿肌压力。数据采用Wilcoxon检验和Kruskal-Wallis检验进行分析。结果-讨论:分析了42例患者(30例男性,12例女性)的数据。病理特征为脊髓损伤、多发性硬化症或多种脊髓病病因。患者接受了1至6次保妥适注射。平均疗效持续时间为6个月。连续注射之间的疗效无差异。43%的患者停用了抗胆碱能药物,48%的患者停止使用护垫。共有80%的患者对治疗满意。70%的患者膀胱收缩消失。平均最大膀胱测压容量增加144毫升。
临床和尿动力学数据表明,重复向逼尿肌注射毒素仍然是治疗神经源性膀胱过度活动症的有效方法。连续注射期间控尿疗效得以维持。